Wellbutrin is not a benzodiazepine. It belongs to a completely different drug class called aminoketones, and it works through an entirely different mechanism in the brain. The confusion likely comes from the fact that both medications are sometimes prescribed for people dealing with anxiety or depression, but they have almost nothing in common pharmacologically.
How Wellbutrin Works
Wellbutrin (bupropion) increases levels of two brain chemicals: norepinephrine and dopamine. It does this by blocking the reabsorption of these neurotransmitters, letting them stay active longer in the brain. It has no meaningful effect on serotonin, which sets it apart from most other antidepressants as well. The FDA label describes it as “chemically unrelated to tricyclic, tetracyclic, selective serotonin reuptake inhibitor, or other known antidepressant agents.”
This mechanism gives Wellbutrin a distinct side effect profile. Because it doesn’t affect serotonin or histamine, it generally doesn’t cause sexual dysfunction, weight gain, or heavy sedation. In fact, the more common complaints run in the opposite direction: trouble sleeping, restlessness, increased energy, and decreased appetite. Some people experience a mild stimulant-like effect, especially early in treatment.
How Benzodiazepines Work
Benzodiazepines target a completely different system. They bind to GABA-A receptors in the brain, which are the primary “slow down” receptors in your nervous system. When GABA attaches to these receptors, it opens a channel that lets chloride ions flow into nerve cells, making them less likely to fire. Benzodiazepines amplify this process by increasing the frequency of that channel opening. The result is sedation, muscle relaxation, and reduced anxiety, often within minutes.
Common benzodiazepines include alprazolam (Xanax), diazepam (Valium), lorazepam (Ativan), and temazepam (Restoril). They’re fast-acting and effective for acute anxiety, panic attacks, and insomnia, but they carry real risks of physical dependence and difficult withdrawal.
Different Legal Classifications
The regulatory difference is stark. All major benzodiazepines are classified as Schedule IV controlled substances by the DEA, meaning they have a recognized potential for abuse and dependence. Wellbutrin does not appear on the DEA’s controlled substances list at all. You won’t face the same prescribing restrictions, and refills are generally simpler to obtain.
Different Withdrawal Risks
Benzodiazepine withdrawal is one of the more serious discontinuation syndromes in medicine. Stopping abruptly after regular use can cause seizures, severe anxiety, insomnia, and a prolonged withdrawal phase that can last weeks or months. Wellbutrin doesn’t carry the same risk. There’s no strong link between bupropion and post-acute withdrawal syndrome, the drawn-out psychological withdrawal that commonly accompanies benzodiazepines, alcohol, and opioids. Tapering is still a reasonable precaution when stopping Wellbutrin, but the process is generally far less complicated.
What Wellbutrin Is Approved For
Wellbutrin has two FDA-approved uses: treatment of major depressive disorder and prevention of seasonal depressive episodes (seasonal affective disorder). A different formulation of the same active ingredient, bupropion sustained-release, is also approved for smoking cessation under the brand name Zyban.
Notably, Wellbutrin is not FDA-approved for any anxiety disorder. This is a key distinction from benzodiazepines, which are primarily prescribed for anxiety. However, a meta-analysis of 10 clinical trials found that bupropion reduced anxiety symptoms in depressed patients just as effectively as SSRIs. So while it isn’t marketed as an anti-anxiety medication, it can improve anxiety that occurs alongside depression. Some clinicians underestimate this effect, tending to avoid bupropion in patients with significant anxiety, but the clinical data doesn’t support that bias.
Wellbutrin’s Unique Risks
Wellbutrin does carry its own safety concern that benzodiazepines don’t share: seizure risk. At doses up to 450 mg per day, the seizure rate is approximately 0.4% (4 in 1,000 patients). Within the standard recommended dose range, that drops to about 0.33%. The risk increases with higher doses, eating disorders, alcohol withdrawal, and other factors that lower the seizure threshold. This is why there’s a firm maximum dose ceiling, and why your prescriber will ask about your seizure history.
Wellbutrin comes in three formulations that differ in how quickly the drug is released. The immediate-release version is taken two or three times daily. The sustained-release (SR) version is taken twice daily, starting at 150 mg once a day and potentially increasing to 150 mg twice daily. The extended-release (XL) version is taken once in the morning, with doses ranging from 150 mg to 300 mg. The XL formulation is the most commonly prescribed today because of its convenience and smoother blood levels throughout the day.
Why People Confuse the Two
The confusion probably stems from the fact that both drugs get discussed in the context of mental health treatment, and both can affect how anxious a person feels. But the overlap ends there. Wellbutrin is an activating antidepressant that boosts dopamine and norepinephrine. Benzodiazepines are sedating anti-anxiety medications that enhance GABA activity. They have different chemical structures, different mechanisms, different side effects, different abuse potential, and different legal classifications. If you’ve been prescribed Wellbutrin, you’re taking an antidepressant, not a tranquilizer.